Universal-Beteiligungs- und Servicegesellschaft’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
22,610
-30,538
-57% -$1.57M ﹤0.01% 1536
2026
Q1
$3.15M Sell
53,148
-5,493
-9% -$356K 0.01% 1072
2025
Q4
$3.62M Sell
58,641
-3,887
-6% -$238K 0.01% 1034
2025
Q3
$3.9M Buy
62,528
+11,637
+23% +$810K 0.01% 983
2025
Q2
$4.06M Buy
50,891
+3,576
+8% +$299K 0.01% 914
2025
Q1
$4.07M Sell
47,315
-52,287
-52% -$4.29M 0.01% 884
2024
Q4
$7.78M Buy
+99,602
New +$7.73M 0.02% 606

Other funds holding PBH

Universal-Beteiligungs- und Servicegesellschaft's PBH Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Prestige Consumer Healthcare (PBH) stake by 57% in Q2 2026, selling an estimated $1.57M and leaving 22,610 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in PBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.78M in Q4 2024. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 22,610 shares of Prestige Consumer Healthcare worth $1.07M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 30,538 Prestige Consumer Healthcare shares in Q2 2026, an estimated $1.57M.
  • Prestige Consumer Healthcare made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1536 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Prestige Consumer Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Prestige Consumer Healthcare position peaked at $7.78M in Q4 2024.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.